Plain-English translation of NCT06336395 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing whether using genetic information from your leukemia cells can help doctors choose the right chemotherapy plan just for you. Doctors will analyze your cancer's genetic profile and how your body responds early in treatment to assign you to a treatment plan (standard, intermediate, or high risk) that gives you the best chance of recovery. All the chemotherapy drugs used in this trial are already approved and commonly used—nothing experimental.
Not all children and young adults with acute lymphoblastic leukemia respond the same way to treatment. This trial exists to see whether personalized treatment plans based on each person's cancer genetics and early treatment response can improve survival and reduce unnecessary side effects.
You likely qualify if…
You likely don't qualify if…
You will receive chemotherapy at a treatment center, with the specific drugs and schedule determined by your leukemia's genetic profile and how your cancer responds in the first few weeks of treatment. Depending on your risk category, you may receive standard chemotherapy, additional targeted antibody therapy, or advanced treatments like CAR-T cell therapy or stem cell transplant. You will have regular blood tests, bone marrow checks, and imaging scans throughout your treatment to monitor your progress.
AI-generated summary from trial data · Jun 9, 2026 · Not medical advice
Malaysia
Singapore